23,025 Shares in Semler Scientific, Inc. (NASDAQ:SMLR) Purchased by X Square Capital LLC

X Square Capital LLC purchased a new position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 23,025 shares of the company's stock, valued at approximately $1,243,000. X Square Capital LLC owned about 0.25% of Semler Scientific at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp purchased a new stake in Semler Scientific during the fourth quarter valued at about $34,000. Larson Financial Group LLC acquired a new stake in Semler Scientific during the 4th quarter worth approximately $38,000. IFP Advisors Inc purchased a new position in Semler Scientific in the fourth quarter valued at approximately $54,000. Quest Partners LLC lifted its position in Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company's stock valued at $59,000 after buying an additional 817 shares in the last quarter. Finally, Global Retirement Partners LLC grew its stake in Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock worth $70,000 after buying an additional 500 shares during the period. Hedge funds and other institutional investors own 49.37% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital raised their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research note on Friday, January 24th.

Remove Ads

Semler Scientific Stock Down 1.5 %

Shares of NASDAQ SMLR traded down $0.56 on Monday, hitting $36.30. The company had a trading volume of 234,099 shares, compared to its average volume of 386,740. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The firm has a market capitalization of $348.41 million, a P/E ratio of 7.41 and a beta of 1.33. The business has a 50 day moving average of $45.47 and a two-hundred day moving average of $44.92.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $3.21. The firm had revenue of $12.41 million during the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.